Stock Price
7.61
Daily Change
-0.50 -6.17%
Monthly
-6.85%
Yearly
-17.10%
Q1 Forecast
7.87



Peers Price Chg Day Year Date
Hitachi 4,718.00 -113.00 -2.34% 27.41% Mar/09
Mitsubishi Electric 5,235.00 -283.00 -5.13% 97.77% Mar/09
Matsui Securities 944.00 -12.00 -1.26% 19.34% Mar/09
Advance Auto Parts 50.48 0.15 0.30% 37.62% Mar/09
AGCO 121.97 -1.91 -1.54% 18.86% Mar/09
Alfa 17.68 -0.43 -2.37% 7.02% Mar/09
AutoZone 3,672.68 31.39 0.86% -0.47% Mar/09
Builders Firstsource 95.15 2.03 2.18% -29.82% Mar/09
Carlisle Companies 344.33 -10.23 -2.89% 2.61% Mar/09
Dover 211.00 2.58 1.24% 18.71% Mar/09

Indexes Price Day Year Date
USND 22696 308.27 1.38% 29.93% Mar/09

Icahn Enterprises traded at $7.63 this Monday March 9th, decreasing $0.48 or 5.92 percent since the previous trading session. Looking back, over the last four weeks, Icahn Enterprises lost 6.61 percent. Over the last 12 months, its price fell by 16.88 percent. Looking ahead, we forecast Icahn Enterprises to be priced at 7.87 by the end of this quarter and at 7.17 in one year, according to Trading Economics global macro models projections and analysts expectations.

Icahn Enterprises L.P. is a holding company. The Company's segments include Investment, Automotive, Energy, Metals, Food Packaging, Metals, Real Estate, Home Fashion and Pharma. The Investment segment includes various private investment funds. The Company operates its Automotive segment through its wholly owned subsidiary, Icahn Automotive Group LLC. It operates Energy segment through its subsidiary, CVR Energy, Inc. Its Food Packaging segment operates through its subsidiary, Viskase Companies, Inc. The Company operates its Metals segment through its subsidiary, PSC Metals, Inc. The Company's Real Estate segment consist of investment properties, development and sale of single-family homes and the management of a club. Its Home Fashion segment through its wholly owned subsidiary, WestPoint Home LLC consists of manufacturing, sourcing, marketing, distributing and selling home fashion consumer products. The Company operates its Pharma segment through its subsidiary, Vivus, Inc.